本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioLine Rx

2.15
-0.0200-0.92%
成交量:6,264
成交额:1.36万
市值:1,070.32万
市盈率:-1.36
高:2.27
开:2.27
低:2.11
收:2.17
52周最高:4.15
52周最低:2.11
股本:497.82万
流通股本:471.65万
量比:0.59
换手率:0.13%
股息:- -
股息率:- -
每股收益(TTM):-1.5822
每股收益(LYR):-0.2856
净资产收益率:-55.27%
总资产收益率:-19.82%
市净率:0.78
市盈率(LYR):-7.53

数据加载中...

2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/30

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/05

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]